首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

2058281

血管內動脈瘤修復市場：依產品類型、適應症、最終用戶和地區分類

Endovascular Aneurysm Repair Market, By Product Type, By Indication, By End User, By Geography

出版日期: 2026年05月08日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，血管內動脈瘤修復市場規模將達到 35 億美元，到 2033 年將達到 65 億美元。預計從 2026 年到 2033 年，該市場將以 6.3% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	35億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.30%	2033年市場規模預測：	65億美元

該市場正經歷顯著的變革，其主要驅動力來自微創手術技術的進步、人口老化以及血管疾病發病率的上升。血管支架應用日益廣泛，能夠改善患者預後，這是市場成長的關鍵因素。與傳統開放性手術相比，經導管主動脈瘤修復術 (EVAR) 為患者帶來許多優勢，例如恢復時間更短、併發症更少。此外，醫療專業人員正在採用先進的影像系統，從而實現更精準的治療，尤其適用於複雜動脈瘤，進而提高手術成功率。

此外，諸如3D影像、機器人輔助導航和改良支架設計等創新技術，使得針對每位患者的個人化治療方案得以最佳化，進一步拓展了市場。術後監測和追蹤護理的整合也有助於提高患者滿意度和改善長期治療效果。而且，隨著人們對腔內血管修復術（EVAR）益處的認知不斷提高，越來越多的患者選擇這種微創治療方法。這些進步正在革新血管治療，使動脈瘤治療更加個人化。

市場動態

血管內動脈瘤修復術（EVAR）市場正在快速擴張。這一成長主要得益於微創手術的日益普及和血管疾病患者數量的不斷增加。隨著全球人口老化，人們對康復更快、併發症更少的治療方法的需求日益成長，而傳統手術則不具備這些優勢。 EVAR透過微創切口血管支架來修復動脈瘤，與傳統開放性手術相比具有顯著優勢。這些優勢，以及血管支架技術的進步，例如耐久性和生物相容性的提高，正推動市場成長，越來越多的患者選擇這種治療方法。

技術進步也對腔內血管修復術（EVAR）市場的成長起到了重要作用。 3D影像、即時診斷工具和機器人輔助手術系統的引入提高了手術的精確度。這些創新不僅增強了EVAR的安全性，也降低了併發症的發生率，縮短了復原時間。此外，遠端醫療和遠端監測解決方案的整合使醫護人員能夠更有效地對患者進行隨訪，從而改善術後護理和長期治療效果。

此外，門診治療模式的普及性和更具成本效益的治療方案的出現，也促進了腔內血管修復術（EVAR）的廣泛應用。多家醫療機構已採用這種模式，旨在縮短住院時間並降低相關費用。隨著醫療機構持續投資先進技術，以及患者對EVAR益處的認知不斷提高，預計市場將持續成長。隨著醫療設備的不斷創新和手術技術的改進，EVAR市場有望為全球患者提供更安全、更有效率、更便利的解決方案。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對血管內動脈瘤修復市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「血管內動脈瘤修復市場」報告旨在為該行業的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析血管內動脈瘤修復市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Medtronic plc.
- Cook Medical
- Gore Medical
- B. Braun Melsungen AG
- Terumo Corporation
- Boston Scientific Corporation
- Abbott Laboratories
- Volcano Corporation
- CR Bard
- Spectranetics International BV
- Cordis Corporation（Johnson and Johnson Co.）
- St. Jude Medical Inc.

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1339

Endovascular Aneurysm Repair Market is estimated to be valued at USD 3.5 Bn in 2026 and is expected to reach USD 6.5 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.5 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.30%	2033 Value Projection:	USD 6.5 Bn

The market is undergoing a major transformation mainly driven by the technological advancements in minimally invasive procedures, an aging population, and the rising incidence of vascular diseases. The increasing adoption of stent grafts, which offer improved patient outcomes, is a key factor in the market's growth. EVAR provides patients with the benefit of reduced recovery times and fewer complications compared to traditional open surgeries. In addition, the healthcare providers are embracing advanced imaging systems, which allow for more precise treatment, especially in complex aneurysms, thus enhancing procedural success rates.

The market is also growing with the innovations like 3D imaging, robotic-assisted navigation, and improved stent designs which help in better customization of treatment for individual patients. The integration of post-operative monitoring and follow-up care is also boosting patient satisfaction as well as long-term outcomes. In addition, as awareness grows regarding the benefits of EVAR, more patients are opting for this minimally invasive alternative. These advancements are revolutionizing vascular care, thereby leading to a more personalized approach to aneurysm treatment.

Market Dynamics

The Endovascular Aneurysm Repair (EVAR) market is expanding at a rapid pace. The growth is mainly owing to the increasing adoption of minimally invasive procedures and the growing number of vascular diseases. As the global population ages, the demand for treatments that offer faster recovery times and fewer complications compared to traditional surgeries is increasing. EVAR, which utilizes stent grafts to repair aneurysms through small incisions, offers substantial advantages over open surgeries. These benefits, along with advancements in stent graft technology like improved durability and biocompatibility are encouraging more patients to opt for this procedure, thereby fueling market growth.

The technological advancements also play a crucial role in the growth of the EVAR market. The introduction of 3D imaging, real-time diagnostic tools, and robotic-assisted surgery systems is improving the precision of these procedures. These innovations not only enhance the safety of EVAR but also reduce the likelihood of complications and shorten recovery times. In addition, the integration of telemedicine and remote monitoring solutions allows healthcare providers to follow up with patients more effectively, thus ensuring better post-operative care and long-term outcomes.

Furthermore, the shift toward outpatient care and cost-effective treatment options is contributing to the increased adoption of EVAR procedures. Several healthcare systems are embracing this model, which focuses on reducing hospital stays and associated costs. As healthcare providers continue to invest in advanced technologies, and as patient awareness of EVAR's advantages grows, the market is expected to experience sustained growth. With further innovation in medical devices and improved procedural techniques, the EVAR market is poised to offer safer, more efficient, and accessible solutions for patients across the world.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Endovascular Aneurysm Repair Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic plc. Cook Medical, Gore Medical, B. Braun Melsungen AG, Terumo Corporation, Boston Scientific Corporation, Abbott Laboratories, Volcano Corporation, C.R. Bard, Spectranetics International BV, Cordis Corporation (Johnson and Johnson Co.), and St. Jude Medical Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Endovascular Aneurysm Repair Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Endovascular Aneurysm Repair Market

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
- Fenestrated Stent Graft
- Adjunctive Stent Graft
- Branched Stent Graft
- Others
By Indication (Revenue, USD Bn, 2021-2033)
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic aneurysm (TAA)
- Descending Aortic Aneurysm
- Ascending Aortic Aneurysm
By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Ambulatory Care Services
- Specialty Clinics
By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin Americ
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Medtronic plc.
- Cook Medical
- Gore Medical
- Braun Melsungen AG
- Terumo Corporation
- Boston Scientific Corporation
- Abbott Laboratories
- Volcano Corporation
- C.R. Bard
- Spectranetics International BV
- Cordis Corporation (Johnson and Johnson Co.)
- Jude Medical Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Endovascular Aneurysm Repair Market, By Product Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Fenestrated Stent Graft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Adjunctive Stent Graft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Branched Stent Graft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Endovascular Aneurysm Repair Market, By Indication, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Abdominal Aortic Aneurysm (AAA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Thoracic Aortic aneurysm (TAA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Segment Trends
  - Descending Aortic Aneurysm
  - Ascending Aortic Aneurysm

6. Global Endovascular Aneurysm Repair Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Ambulatory Care Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Endovascular Aneurysm Repair Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Medtronic plc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cook Medical
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Gore Medical
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- B. Braun Melsungen AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Terumo Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Boston Scientific Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Volcano Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- C.R. Bard
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Spectranetics International BV
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cordis Corporation (Johnson and Johnson Co.)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- St. Jude Medical Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views